AGN 0.73% 68.0¢ argenica therapeutics limited

Ann: Preliminary Pre-Clinical Tox Studies Successfully Completed, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,536 Posts.
    lightbulb Created with Sketch. 510
    Sounds like Phase 1 trial likely to commence Q2. Bit of a delay, but not unusual.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.